Medicine

Medicare to Cover Wegovy for Certain Indications

March 23, 2024 - By 

The drug was recently cleared to treat cardiovascular risks, making it eligible for Medicare Part D.

Related Posts

FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk

February 19, 2025

Navigating Distrust: Pharma in the Age of Social Media

February 19, 2025

Pharmaceutical Executive: February 2025 Issue (PDF)

February 18, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *